Stock screener

KOD

Conviction 82HealthcareScan · Thu, Jun 25, 2026
KOD$34.09-5.31%
ResistanceSupportVol 14Insider sell
63 bars
2
Vol MA14 822.18K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Kodiak Sciences Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.kodiak.com
Price34.09
Change-5.31%
Gap+1.33%
Rel volume2.42×
Avg volume788.78K
Avg $ vol26.85M
SMA 2034.24
SMA 5038.42
SMA 20026.90
Price vs 50-11.27%
Price vs 200+26.72%
MA stackmixed
50/200 cross
Supertrenddown · 38.44
RSI (14)46
MACD hist0.48
MACD crossbull · 7d
Stoch %K / %D52 / 69
ADX (14)17
+DI / −DI18 / 20
RSI divergence
MACD divergence
ATR %+8.23%
ADR %7.95%
52w high46.44
52w low3.69
From 52w high-26.59%
Above 52w low+823.85%
New 52w highNo
SqueezeOff
Bollinger width25.06%
%B0.48
Donchian pos52.03%
Donchian high38.59
Donchian low29.21
AVWAP (52w high)37.35
vs AVWAP high-8.72%
AVWAP (52w low)24.91
vs AVWAP low+36.85%
OBV trendUp
Chaikin MF (20)-0.25
Today vs 20d2.42×
Avg vol (14d)822.18K
Avg vol (20d)788.78K
Avg $ vol (20d)26.85M
Market cap2.13B
RS 3m (vs SPY)+52.50%
RS 6m (vs SPY)+30.73%
RS line new highNo
Trend template6/8
Technical rank61.3
1 week-4.54%
1 month-5.31%
3 months+49.85%
6 months+19.15%
1 year+844.32%
YTD+31.01%
P/E-9.28
P/B19.03
P/S
P/FCF-15.63
EPS-4.32
Div yield
ROE-205.14%
ROA-75.15%
Debt/Eq
Current3.54
EV/EBITDA
Gross margin
Net margin
Rev growth
EPS growth-30.51%
Price target62.67
Target upside83.84%
Analyst ratingBuy
Institutional96.56%
Ent. value1.96B
Revenue
Net income-58.16M
Gross profit
Free cash flow-136.51M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out62.58M
Employees124
ListedThu, Oct 4, 2018
Free float28.06M
Float %45.4%
Short interest10.32M
Days to cover17.2d
Short volume41.0%
Squeeze score81 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.94 vs −$0.93
Last surprise-1.1% miss
Setup gradeA
Conviction82 / 100
Pattern quality
Tech rank61.3 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance43.60
Support30.88
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in KOD

All disclosures →
No recent disclosed trades by Congress in KOD. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KOD · 2 buys · 4 sells

InsiderSideShares
BORGESON JOHN A.
Chief Financial Officer · Stock Option (Right to Buy) · 2026-06-04
Exercise30K
BORGESON JOHN A.
Chief Financial Officer · Common Stock · 2026-06-04
Sell25.9K
BORGESON JOHN A.
Chief Financial Officer · Common Stock · 2026-06-04
Exercise30K
BORGESON JOHN A.
Chief Financial Officer · Common Stock · 2026-06-04
Sell4.1K
BORGESON JOHN A.
Chief Financial Officer · Common Stock · 2026-04-15
Exercise28.61K
BORGESON JOHN A.
Chief Financial Officer · Stock Option (Right to Buy) · 2026-04-15
Exercise28.61K

SEC filings

EDGAR filings in KOD · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.